FDA's CBE Codification Could Help Defendants
FDA has just proposed amendments to the regulations governing a drug, biologic, or medical device manufacturer's ability to implement labeling changes in advance of agency review and approval. See Supplemental Applications...To view the full article, register now.
Already a subscriber? Click here to view full article